Clinical Trial Update: Role of Myeloid-derived Suppressor Cells In Primary Myelofibrosis

View source ↗

Summary

The study investigates the role of myeloid-derived suppressor cells in primary myelofibrosis, and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Primary Myelofibrosis (PMF), Healthy Subjects | Status: COMPLETED